Putative Neuroleptic Malignant Syndrome Associated With Sertraline Withdrawal
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Konstantakopoulos, George MD; Kouzoupis, Anastasios V. MD; Papageorgiou, Sokratis G. MD; Oulis, Panagiotis MD, PhD Author Information
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two open trials of fluvoxamine involving respectively 17 obsessive-compulsive disorder [48] and 14 panic disorder [3] patients systematically reported the emergence of withdrawal syndromes.”
From Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review (2015) · cites this paper as [48]
In the citing paper
“Twenty-three percent of obsessive-compulsive disorder patients [48] and 85.7% of PD patients [3] experienced dizziness, nausea, headache, confusion, low energy, and weakness that abated in about 2-3 weeks.”
From Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review (2015) · cites this paper as [48]
Citations
Cites
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.6.705 · Cited by 1,342
Neuroleptic malignant syndrome
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.10.1137 · Cited by 978
Selective Serotonin Reuptake Inhibitor-Induced Serotonin Syndrome: Review
Lane, R., & Baldwin, D. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199706000-00012 · Cited by 247
Northoff, G., Steinke, R., Czcervenka, C., Krause, R., Ulrich, S., Danos, P., Kropf, D., Otto, H., & Bogerts, B. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.4.445 · Cited by 211
Neuroleptic malignant syndrome and catatonia: One entity or two?
Fink, M. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00552-8 · Cited by 164
Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case–control study
Berardi, D., Amore, M., Keck, P. E., Troia, M., & Dell’Atti, M. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00530-1 · Cited by 150
Malignant syndrome in Parkinson's disease: concept and review of the literature
Mizuno, Y., Takubo, H., Mizuta, E., & Kuno, S. (2003) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(02)00125-6 · Cited by 102
Pharmacologic Differences Among the SSRIs: Focus on Monoamine Transporters and the HPA Axis
Nemeroff, C. B., & Owens, M. J. (2004) · CNS Spectrums · doi:10.1017/s1092852900025475 · Cited by 93
Pathogenesis and treatment of neuroleptic malignant syndrome
Ebadi, M., Pfeiffer, R. F., & Murrin, L. C. (1990) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(90)90685-f · Cited by 74
Fluoxetine and neuroleptic malignant syndrome
Halman, M. H., & Goldbloom, D. S. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90485-k · Cited by 73
Cited by
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436
Antidepressant discontinuation reactions: Are preventable and simple to treat
Haddad, P., Lejoyeux, M., & Young, A. (1998) · BMJ · doi:10.1136/bmj.316.7138.1105 · Cited by 286
Pannu, A. S., & Goyal, R. K. (2024) · Current Drug Safety · doi:10.2174/0115748863301630240417071353 · Cited by 29
“Burn Catatonia”: A Case Report and Literature Review
Quinn, D. K. (2013) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e31828c73c7 · Cited by 11
Metadata
- Authors
- Konstantakopoulos, G., Kouzoupis, A. V., Papageorgiou, S. G., & Oulis, P.
- Affiliations
- Eginition Hospital (GR)
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2009-06
- Volume
- 29
- Issue
- 3
- Pages
- 300-301
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W1964953041
- Cited by
- 11
- References
- 17
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2018: 1 · 2016: 1 · 2015: 1 · 2013: 1
- FWCI
- 0.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- neuroleptic malignant syndrome, sertraline, antidepressant discontinuation, selective serotonin reuptake inhibitors, adverse drug reactions
- MeSH terms
- Aged, Major Depressive Disorder, Female, Humans, Neuroleptic Malignant Syndrome, Substance Withdrawal Syndrome, Selective Serotonin Reuptake Inhibitors, Sertraline
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Putative Neuroleptic Malignant Syndrome Associated With Sertraline Withdrawal. https://app.cochat.ai/papers/10.1097/jcp.0b013e3181a39101
- The paper
- Konstantakopoulos, G., Kouzoupis, A. V., Papageorgiou, S. G., & Oulis, P. (2009). Putative Neuroleptic Malignant Syndrome Associated With Sertraline Withdrawal. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0b013e3181a39101
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.